Out of over 200 marijuana stocks, there’s five that we’re going to be watching as the markets open due to breaking news out this morning.
Here’s five cannabis companies to watch today including 22nd Century Group Inc. (NYSE:XXII) and more.
22nd Century Group Inc. (NYSE:XXII)
Today, the Johns Hopkins Bloomberg School of Public Health will host the public health community’s first opportunity to discuss the groundbreaking vision of the US Food and Drug Administration to reduce nicotine in cigarettes to non-addictive levels. This is expected to move shares of XXII given the company’s substantial patent portfolio surrounding their very low nicotine tobacco/cigarettes.
CannaRoyalty Corp. (CSE:CRZ) (OTC:CNNRF)
This morning, CannaRoyalty Corp. announced the official launch of its first CR Brands product in California through CannaRoyalty investee River Collective, California’s largest cannabis distributor. The company has started selling Soul Sugar Kitchen gourmet-edibles through River’s distribution network of 677 dispensaries in California, and is on track to launch GreenRock Botanicals premium vape pens this quarter.
Cronos Group Inc. (TSXV:MJN) (OTC:PRMCF)
This morning, Cronos Group Inc. announced that it has entered into a letter of engagement with PI Financial Corp. as sole lead underwriter. PI has agreed to purchase for re-sale 4,761,905 common shares of the company, on a “bought deal” basis pursuant to the filing of a short form prospectus, subject to all required regulatory approvals, at a price per share of $3.15 CAD, for total gross proceeds of $15,000,000.75 CAD, equivalent to roughly $12,016,500.60 USD at current foreign exchange rates.
Marapharm Ventures Inc. (CSE:MDM) (OTC:MRPHF)
This morning, Marapharm Ventures Inc. announced that it has today filed an early warning report advising that it has purchased a total of 1,500,000 units of Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) at a purchase price of $0.28 CAD per unit, each unit consisting of one common share in the share capital of the issuer and one common share purchase warrant of the issuer, exercisable at a price of $0.45 CAD per common share for a period of 18 months.
Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF)
This morning, Marapharm Ventures Inc. announced that it has today filed an early warning report advising that it has purchased a total of 1,500,000 units of Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) at a purchase price of $0.28 CAD per unit, each unit consisting of one common share in the share capital of the issuer and one common share purchase warrant of the issuer, exercisable at a price of $0.45 CAD per common share for a period of 18 months.
This story was originally published in The Daily Marijuana Observer. You can connect with them on on social media via Facebook, Twitter, StockTwits, YouTube, and Instagram.
